AIRSUPRA: payments to doctors
Payments that named AIRSUPRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $26M
- Providers
- 80,952
- Transactions
- 364,098
- Average per transaction
- $71
The per-transaction average — $71 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 80,952 providers the average total is $321, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $25,977,584 | 100.0% |
| Astrazeneca AB | $6,588 | 0.0% |
| Astrazeneca UK Limited | $2,858 | 0.0% |